MedPath
TGA Approval

SERBEHISTIN betahistine dihydrochloride 16 mg tablets blister packs (212083)

212083

SERBEHISTIN betahistine dihydrochloride 16 mg tablets blister packs

Arrotex Pharmaceuticals Pty Ltd

August 14, 2014

Medicine

Medicine

Active

Registered

Active Ingredients

betahistine dihydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SERBEHISTIN betahistine dihydrochloride 16 mg tablets blister packs (212083) - TGA 批准文号 | MedPath